The use of antipsychotics in children and adolescents with bipolar disorders

• GELLER B, BOLHOFNER K, CRANEY JL, DELBELLO MP, GUNDERSON K: Psychosocial functioning in a prepubertal and early adolescent bipolar disorder phenotype. J. Am. Child Adolesc. Psychiatry (2000) 39(12):1543-1548.
   PubMed Web of Science ®Google Scholar
• LEWINSOHN PM, KLEIN DN, SEELY JR: Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. J. Am. Acad. Child Adolesc. Psychiatry (1995) 34(4):454-463.
   PubMed Web of Science ®Google Scholar
• GELLER B, LUBY J: Child and adolescent bipolar disorder: a review of the past 10 years. J. Am. Acad. Child Adolesc. Psychiatry (1997) 36(9):1168-1176.
   PubMed Web of Science ®Google Scholar
• WEINBERG WA, REHMET A: Childhood affective disorder and school problems. In: Affective Disorders in Childhood and Adolescence: An Update. Cantwell DP, Carlson GP (Ed.), Spectrum Publishing, Inc., Jamaica, NY (1983):109-128.
   Google Scholar
• WILENS TE, BIEDERMAN J, MILLSTEIN RB, WOZNIAK J, HAHESY AL, SPENCER TJ: Risk for substance use disorders in youths with child- and adolescent-onset bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry (1999) 38(6):680-685.
   PubMed Web of Science ®Google Scholar
• GOLDSTEIN TR, BIRMAHER B, AXELSON D et al.: History of suicide attempts in pediatric bipolar disorder: factors associated with increased risk. Bipolar Disord. (2005) 7(6):525-535.
   PubMed Web of Science ®Google Scholar
• YOUNGSTROM EA, DUAX J: Evidence-based assessment of pediatric bipolar disorder, part I: base rate and family history. J. Am. Acad. Child Adolesc. Psychiatry (2005) 44(7):712-717.
   PubMed Web of Science ®Google Scholar
• FARAONE SV, GLATT SJ, TSUANG MT: The genetics of pediatric-onset bipolar disorder. Biol. Psychiatry (2003) 53(11):970-977.
   PubMed Web of Science ®Google Scholar
• PERLIS RH, MIYAHARA S, MARANGELL LB et al.: Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol. Psychiatry (2004) 55(9):875-881.
   PubMed Web of Science ®Google Scholar
• DABIELYAN A, KOWATCH RA: Management options for bipolar disorder in children and adolescents. Paediatr. Drugs (2005) 7(5):277-294.
   PubMedGoogle Scholar
• TOHEN M, KETTER TA, ZARATE CA et al.: Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am. J. Psychiatry (2003) 160:1263-1271.
   PubMed Web of Science ®Google Scholar
• KECK PE Jr, CALABRESE JR, MCQUADE RD et al.: A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. J. Clin. Psychiatry (2006) 67(4):626-637.
   PubMed Web of Science ®Google Scholar
• KECK PE Jr, VERSIANI M, POTKIN S, WEST SA, GILER E, ICE K: Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am. J. Psychiatry (2003) 160(4):741-748.
   PubMed Web of Science ®Google Scholar
• BOWDEN CL, MYERS JE, GROSSMAN F, XIE Y: Risperidone in combination with mood stabilizers: a 10-week continuation phase study in bipolar I disorder. J. Clin. Psychiatry (2004) 65(5):707-714.
   PubMed Web of Science ®Google Scholar
• PERLIS RH, WELDGE JA, VORNICK LA, HIRSCHFELD RM, KECK PE Jr: Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials. J. Clin. Psychiatry (2006) 67(4):509-516.
   PubMed Web of Science ®Google Scholar
• STAHL SM: Essential psychopharmacology: antipsychotic agents. In: Neuroscientific Basis and Practical Applications. (2nd Edition). Cambridge University Press, New York (2000):401-458.
   Google Scholar
• FINDLING RL, STEINER H, WELLER EB: Use of antipsychotics in children and adolescents. J. Clin. Psychiatry (2005) 66(Suppl. 7):29-40.
   PubMed Web of Science ®Google Scholar
• KAFANTARIS V, COLETTI DJ, DICKER R, PADULA G, KANE JM: Adjunctive antipsychotic treatment if adolescents with bipolar psychosis. J. Am. Acad. Child Adolesc. Psychiatry (2001) 40(12):1448-1456.
   PubMed Web of Science ®Google Scholar
• KAFANTARIS V, COLETTI DJ, DICKER R et al.: Lithium treatment of acute mania in adolescents: a large open trial. J. Am. Acad. Child Adolesc. Psychiatry (2003) 42(9):1038-1045.
   PubMed Web of Science ®Google Scholar
• SIKICK L, HAMER RM, BASHFORD RA, SHEITMAN BB, LIEBERMAN JA: A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double blind, randomized, 8-week trial. Neuropsychopharmacology (2004) 29:133-145.
   PubMed Web of Science ®Google Scholar
• NASRALLAH HA: Focus on lower risk of tardive dyskinesia with atypical antipsychotics. Ann. Clin. Psychiatry (2006) 18(1):57-62.
   PubMedGoogle Scholar
• KAPUR S, AGID O, MIZRAHI R, LI M: How antipsychotics work – from receptor to reality. NeuroRx (2006) 3(1):10-21.
   PubMedGoogle Scholar
• BUCKLEY PF, MILLER DD, SINGER B, DONENWIRTH K: What's new with the new antipsychotics? Presented at the Annual Meeting of the American College of Neuropsychopharmacology. Acapulco, Mexico (1999).
   Google Scholar
• CLARK C, BURGE MR: Diabetes mellitus associated with atypical anti- psychotic medications. Diabetes Technol. Ther. (2003) 5(4):669-683.
   PubMedGoogle Scholar
• LEBOVITZ HE: Metabolic consequences of atypical antipsychotic drugs. Psychiatr. Q. (2003) 74(3):277-290.
   PubMed Web of Science ®Google Scholar
• LIEBERMAN JA, STROUP TS, MCENVOY JP et al.: Effectiveness of antipsychotic drugs in patients with schizophrenia. N. Engl. J. Med. (2005) 353(12):1209-1223.
   PubMed Web of Science ®Google Scholar
• GELLER B, COOPER TB, SUN K et al.: Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J. Am. Acad. Child Adolesc. Psychiatry (1998) 37(2):171-178.
   PubMed Web of Science ®Google Scholar
• PATEL NC, DELBELLO MP, BRYAN HS et al.: Open-label lithium for the treatment of adolescents with bipolar depression. J. Am. Acad. Child Adolesc. Psychiatry (2006) 45(3):289-297.
   PubMed Web of Science ®Google Scholar
• KASTNER T, FRIEDMAN DL, PLUMMER AT, RUIZ MD, HENNING D: Valproic acid for the treatment of children with mental retardation and mood symptomology. Pediatrics (1990) 86(3):467-472.
   PubMed Web of Science ®Google Scholar
• KASTNER T, FRIEDMAN DL: Verapamil and valproic acid treatment of prolonged mania. J. Am. Acad. Child Adol. Psychiatry (1992) 31(2):271-275.
   PubMed Web of Science ®Google Scholar
• PAPATHEODOROU G, KUTCHER SP: Divalproex sodium treatment in late adolescent and young adult acute mania. Psychopharmacol. Bull. (1993) 29(2):213-219.
   PubMedGoogle Scholar
• WEST SA, KECK PEJ, MCELROY SL et al.: Open trial of valproate in the treatment of adolescent mania. J. Child Adolesc. Psychopharmacol. (1994) 4:263-267.
   Web of Science ®Google Scholar
• PAPATHEODOROU G, KUTCHER SP, KATIC M, SZALAI JP: The efficacy and safety of divalproex sodium in the treatment of acute mania in adolescents and young adults: an open clinical trial. J. Clin. Psychopharmacol. (1995) 15(2):110-116.
   PubMed Web of Science ®Google Scholar
• KOWATCH RA, SUPPES T, CARMODY TJ et al.: Effect size of lithium, divalproex sodium and carbamazepine in children and adolescents with bipolar disorder. J. Am. Acad. Child Adol. Psychiatry (2000) 39(6):713-720.
   PubMed Web of Science ®Google Scholar
• CHANG K, SAXENA K, HOWE M: An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression. J. Am. Acad. Child Adolesc. Psychiatry (2006) 45(3):298-304.
   PubMed Web of Science ®Google Scholar
• DELBELLO MP, FINDLING RL, KUSHNER S et al.: A pilot controlled trial of topirimate for mania in children and adolescents with ipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry (2005) 15(6):931-937.
   Google Scholar
• FINDLING RL, MCNAMARA NK, YOUNGSTROM EA et al.: Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry (2005) 44(5):409-417.
   PubMed Web of Science ®Google Scholar
• FINDLING RL, MCNAMARA NK, STANSBREY R et al.: Combination lithium and divalproex sodium in pediatric bipolar symptom re-stabilization. J. Am. Acad. Child Adolesc. Psychiatry (2006) 45(2):142-148.
   PubMed Web of Science ®Google Scholar
• KOWATCH RA, DELBELLO MP: Pharmacotherapy of children and adolescents with bipolar disorder. Psychiat. Clin. North Am. (2005) 28:385-387.
   PubMed Web of Science ®Google Scholar
• KOWATCH RA, DELBELLO MP: The use of mood stabilizers and atypical antipsychotics in children and adolescents with bipolar disorders. CNS Spectr. (2003) 8:273-280.
   PubMed Web of Science ®Google Scholar
• PATEL NC, CRISMON ML, HOAGWOOD K, JOHNSRUD MT, RASCATI KL, WILSON JP: Physician specialty associated with antipsychotic prescribing for youths in the Texas Medicaid program. Med. Care (2006) 44(1):87-90.
   PubMed Web of Science ®Google Scholar
• PATEL NC, CRISMON ML, HOAGWOOD K et al.: Trends in the use of typical and atypical antipsychotics in children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry (2005) 44(6):548-556.
   PubMed Web of Science ®Google Scholar
• OLFSON M, BLANCO C, LIU L, MORENCO C, LAJE G: National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch. Gen. Psychiatry (2006) 63(6):670-685.
   Google Scholar
• CURTIS LH, MASSELINK LE, OSTBYTE T et al.: Prevalence of atypical antipsychotic drug use among commercially insured youths in the United States. Arch. Pediatr. Adolesc. Med. (2005) 159:362-366.
   PubMed Web of Science ®Google Scholar
• PATEL NC, CRISMON ML, SAFER A: Diagnosis and antipsychotic treatment among youths in a public mental health system. Ann. Pharmacother. (2006) 40(2):205-211.
   PubMed Web of Science ®Google Scholar
• KANT R, CHALANSANI R, CHENGAPPA KN, DIERINGER MF: The off-label use of clozapine in adolescents with bipolar disorder, intermittent explosive disorder, or posttraumatic stress disorder. J. Child Adolesc. Psychopharmacol. (2004) 14(1):57-63.
   PubMed Web of Science ®Google Scholar
• CHENG-SHARRON J, MCGOUGH JJ, PATAKI C, MCCRACKEN JT: Second-generation antipsychotic medications in children and adolescents. J. Child Adolesc. Psychopharmacol. (2004) 14(3):372-394.
   PubMed Web of Science ®Google Scholar
• FUCHS DC: Clozapine treatment of bipolar disorder in a young adolescent. J. Am. Acad. Child Adolesc. Psychiatry (1994) 33(9):1299-1302.
   PubMed Web of Science ®Google Scholar
• MASI G, MILONE A: Clozapine treatment in an adolescent with bipolar disorder. Panminerva Med. (1998) 40(3):254-257.
   PubMed Web of Science ®Google Scholar
• MASI G, MUCCI M, MILLEPIEDI S: Clozapine in adolescent inpatients with acute mania. J. Child Adolesc. Psychopharmacol. (2002) 12(2):93-99.
   PubMed Web of Science ®Google Scholar
• KOWATCH RA, SUPPES T, GILFILLIN SK: Clozapine treatment of children and adolescents with bipolar disorder and schizophrenia: a clinical case series. J. Child Adolesc. Psychopharm. (1995) 5(4):241-253.
   Web of Science ®Google Scholar
• KEKS NA, CULHANE C: Risperidone (risperdal): clinical experience with a new antipsychotic drug. Expert Opin. Investig. Drugs (1999) 8(4):443-452.
   PubMedGoogle Scholar
• RATZONI G, GOTHELF D, BRAND-GOTHELF A et al.: Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study. J. Am. Acad. Child Adolesc. Psychiatry (2002) 41:337-343.
   PubMed Web of Science ®Google Scholar
• PAPPAGALLO M, SLIVA R: The effect of atypical antipsychotic agents on prolactin levels in children and adolescents. J. Child Adolesc. Psychopharmacol. (2004) 14(3): 359-371.
   PubMed Web of Science ®Google Scholar
• SAITO E, CORRELL CU, GALLELLI K et al.: A prospective study of hyperprolactinemia in children and adolescents treated with atypical antipsychotic agents. J. Child Adolesc. Psychopharmacol. (2004) 13(3):350-358.
   Google Scholar
• STALLER J: The effect of long-term antipsychotic treatment on prolactin. J. Child Adolesc. Psychopharmacol. (2006) 16(3):317.
   PubMed Web of Science ®Google Scholar
• SAXENA K, CHANG K, STEINER H: Treatment of aggression with risperidone in children and adolescents with bipolar disorder: a case series. Bipolar. Disord. (2006) 8:405-410.
   PubMed Web of Science ®Google Scholar
• FRAZIER J, MEYER M, BIEDERMAN J et al.: Risperidone treatment for juvenile bipolar disorder: a retrospective chart review. J. Am. Acad. Child Adolesc. Psychiatry (1999) 38(8):960-965.
   PubMed Web of Science ®Google Scholar
• BIEDERMAN J, MICK E, WOZNIAK J, ALEARDI M, SPENCER T, FARONE SV: An open-label trial of risperidone in children and adolescents with bipolar disorder. J. Child Adolesc. Psychopharmacol. (2005) 15(2):311-317.
   PubMed Web of Science ®Google Scholar
• BIEDERMAN J, MICK E, HAMMERNESS P et al.: Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in pre-school children. Biol. Psychiatry (2005) 58(7):589-594.
   PubMed Web of Science ®Google Scholar
• AMAN MG, DESMEDT G, DERIVAN A et al.: Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am. J. Psychiatry (2002) 159(8):1337-1346.
   PubMed Web of Science ®Google Scholar
• BIEDERMAN J, MICK E, FARONE SV, WOZNIAK J, SPENCER T, PANDINA G: Risperidone for the treatment of affective symptoms in children with disruptive behavior disorder: a post hoc analysis of data from a 6-week, multicenter, randomized, double-blind, parallel-arm study. Clin. Ther. (2006) 28(5):794-800.
   PubMed Web of Science ®Google Scholar
• KECK PE Jr, MCELROY SL: Bipolar disorder, obesity, and pharmacotherapy-associated weight gain. J. Clin. Psychiatry (2003) 64(12):1426-1435.
   PubMed Web of Science ®Google Scholar
• BLOCH Y, VARDI O, MENDLOVIC S, LEVKOVITZ Y, GOTHELF D, RATZONI G: Hyperglycemia from olanzapine treatment in adolescents. J. Child Adolesc. Psychopharmacol. (2003) 13:97-102.
   PubMed Web of Science ®Google Scholar
• CHANG K, KETTER T: Mood stabilizer augmentation with olanzapine in acutely manic children. J. Child Adolesc. Psychopharm. (2000) 10(1):45-49.
   PubMed Web of Science ®Google Scholar
• SOUTULLO C, SORTER M, FOSTER K, McELROY S, KECK PE: Olanzapine in the treatment of adolescent acute mania: a report of seven cases. J. Affect. Disord. (1999) 53(3):279-283.
   PubMed Web of Science ®Google Scholar
• KHOUZAM HR, EL-GABALAWI F: Treatment of bipolar I disorder in an adolescent with olanzapine. J. Child Adolesc. Psychopharm. (2000) 10(2):147-151.
   PubMed Web of Science ®Google Scholar
• FRAZIER JA, BIEDERMAN J, TOHEN M et al.: A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J. Child Adolesc. Psychopharm. (2001) 11(3):239-250.
   PubMed Web of Science ®Google Scholar
• TOHEN M, KRYZHANOVSKAYA L, CARLSON GA et al.: Olanzapine versus placebo in the treatment of acute mania in adolescents with bipolar disorder: efficacy and safety results of a 3-week, randomized, double-blind study. American College of Neuropharmacology, Waikoloa, HI (2005).
   Google Scholar
• RICHELSON E, SOUNDER T: Binding of antipsychotic drugs to human brain receptors: focus on newer generation compounds. Life Sci. (2000) 68(1):29-39.
   PubMed Web of Science ®Google Scholar
• FINDLING RL, REED MD, O'RIORDAN MA, DEMETER CA, STANSBREY RJ, MCNAMARA NK: Effectiveness, safety, and pharmacokinetics of quetiapine in aggressive children with conduct disorder. J. Am. Acad. Child Adolesc. Psychiatry (2006) 45(7):792-800.
   PubMed Web of Science ®Google Scholar
• MCCONVILLE B, CARRERO L, SWEITZER D et al.: Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial. J. Child Adolesc. Psychopharmacol. (2003) 13(1):75-82.
   PubMed Web of Science ®Google Scholar
• SHAHZAD S, SULEMAN MI, SHAHAB H et al.: Cataract occurrence with antipsychotic drugs. Psychosomatics (2002) 43(5):354-359.
   PubMed Web of Science ®Google Scholar
• SCHALLER JL, BEHAR D: Quetiapine for refractory mania in a child. J. Am. Acad. Child Adolesc. Psychiatry (1999) 38(5):498-499.
   PubMed Web of Science ®Google Scholar
• CATAPANO-Friedman L: Effectiveness of quetiapine in the management of psychotic depression in an adolescent boy with bipolar disorder, mixed, with psychosis. J. Child Adolesc. Psychopharmacol. (2001) 11(2):205-206.
   PubMed Web of Science ®Google Scholar
• MARCHAND WR, WIRTH L, SIMON C: Quetiapine adjunctive and monotherapy for pediatric bipolar disorder: a retrospective chart review. J. Child Adolesc. Psychopharmacol. (2004) 14(3):405-411.
   PubMed Web of Science ®Google Scholar
• DELBELLO MP, SCHWIERS ML, ROSENBERG HL, STRAKOWSKI SM: A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J. Am. Acad. Child Adolesc. Psychiatry (2002) 41(10):1216-1223.
   PubMed Web of Science ®Google Scholar
• DELBELLO MP, KOWATCH RA, ADLER CM et al.: A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J. Am. Acad. Child Adolesc. Psychiatry (2006) 45(3):305-313.
   PubMed Web of Science ®Google Scholar
• BLAIR J, SCAHILL L, STATE M, MARTIN A: Electrocardiographic changes in children and adolescents treated with ziprasidone: a prospective study. J. Am. Acad. Child Adolesc. Psychiatry (2005) 44(1):73-79.
   PubMed Web of Science ®Google Scholar
• NEMEROFF CB, LIEBERMAN JA, WEIDEN PJ et al.: From clinical research to clinical practice: a 4-year review of ziprasidone. CNS Spectr. (2005) 10(11):1-20.
   PubMed Web of Science ®Google Scholar
• BARNETT MS: Ziprasidone monotherapy in pediatric bipolar disorder. J. Adolesc. Psychopharm. (2004) 14:471-477.
   PubMed Web of Science ®Google Scholar
• BURRIS KD, MOLSKI TF, XU C et al.: Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J. Pharmacol. Exp. Ther. (2002) 302(1):381-389.
   PubMed Web of Science ®Google Scholar
• BARZMAN DH, DELBELLO MP, KOWATCH RA et al.: The effectiveness and tolerability of aripiprazole for pediatric bipolar disorder. J. Child Adolesc. Psychopharmacol. (2004) 14(4):693-600.
   Google Scholar
• BIEDERMAN J, MCDONNELL MA, WOZNIAK J et al.: Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review. CNS Spectr. (2005) 10(2):141-148.
   PubMed Web of Science ®Google Scholar
• RUGINO TA, JAVIER YM: Aripiprazole in children and adolescents: clinical experience. J. Child Neurol. (2005) 20(7):603-610.
   PubMed Web of Science ®Google Scholar
• BOWDEN CL: Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder. J. Clin. Psychiatry (2005) 66(Suppl. 3):12-19.
   PubMed Web of Science ®Google Scholar
• KOWATCH RA, SETHURAMAN G, HUME JH, KROMELIS M, WEINBERG WA: Combination pharmacotherapy in children and adolescents with bipolar disorder. Biol. Psychiatry (2003) 53:978-984.
   PubMed Web of Science ®Google Scholar
• PAVULARI MN, HENRY DB, CARBRAY JA, SAMPSON G, NAYLOR MW, JANICAK PG: Open-label prospective trial of risperidone in combination with lithium or divalproex in pediatric mania. J. Affect. Disord. (2004) 82(Suppl. 1):103-111.
   Google Scholar
• TOHEN M, VIETA E, CALABRESE J et al.: Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch. Gen. Psychiatry (2003) 60(11):1079-1088.
   PubMed Web of Science ®Google Scholar
• SOUTULLO CA, DELBELLO MP, OCHSNER JE et al.: Severity of bipolarity in hospitalized manic adolescents with history of stimulant or antidepressant treatment. J. Affect. Disord. (2002) 70:323-327.
   PubMed Web of Science ®Google Scholar
• BRIDGE JA, IYENGAR S, SALARY CB et al.: Clincical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA (2007) 297(15):1683-1696.
   PubMed Web of Science ®Google Scholar
• Treatment guidelines for children and adolescents with bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry (2007) 46(1):107-125.
   Google Scholar
• DINEEN WAGNER K: Bipolar disorder and comorbid anxiety disorders in children and adolescents. J. Clin. Psychiatry (2006) 67(Suppl.):16-20.
   Google Scholar
• BIEDERMAN J, MICK E, SPENCER TJ, WILENS TE, FARAONE SV: Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young. J. Child Adolesc. Psychopharmacol. (2000) 10(3):185-192.
   PubMed Web of Science ®Google Scholar
• KOWATCH RA, DELBELLO MP: Pediatric bipolar disorder: emerging diagnostic and treatment options. Child Adolelesc. Psychiatr. Clin. North Am. (2006) 15(1):931-937.
   Google Scholar
• BIEDERMAN J, SPENCERT, WILENS T et al.: Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int. J. Neuropsychopharmacol. (2004) 7:77-97.
   PubMed Web of Science ®Google Scholar
• ADLER CM, DELBELLO MP, MILLS NP, SCHMOTHORST V, HOLLAND S, STRAKOWSKI SM: Comorbid ADHD is associated with altered patterns of neuronal activation in adolescents with bipolar disorder performing a simple attention task. Bipolar Disord. (2005) 7(6):577-588.
   PubMed Web of Science ®Google Scholar
• KOWATCH RA, FRISTAD M, BIRMAHER B et al.: Treatment guidelines for children and adolescents with bipolar disorder: child psychiatric workgroup on bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry (2005) 44:213-235.
   PubMed Web of Science ®Google Scholar
• AMERICAN DIABETES ASSOCIATION; ASSOCIATION AP: Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care (2004) 27(2):596-601.
   PubMed Web of Science ®Google Scholar
• COOK S, WEITZMAN M, AUUNGER P, NGUYEN M, DIETZ WH: Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National health and nutrition examination survey, 1988 – 1994. Arch. Pediatr. Adolesc. Med. (2003) 157:821-827.
   PubMed Web of Science ®Google Scholar
• KLEIN DJ, COTTINGHAM EM, SORTER M, BARTON BA, MORRISON JA: A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain assoviated with initiation of atypical antipsychotic therapy in children and adolescents. Am. J. Psychiatry (2006) 163(12):2072-2079.
   PubMed Web of Science ®Google Scholar
• HANFT A, EGGLESTON CF, BOURGEOIS JA: Neuroleptic malignant syndrome in an adolescent after brief exposure to olanzapine. J. Child Adolesc. Psychopharmacol. (2004) 14(3):481-487.
   PubMed Web of Science ®Google Scholar
• SKARPATHIOTAKIS M, WESTREICH N: NMS after clozapine initiation. J. Am. Acad. Child Adolesc. Psychiatry (2005) 44(11):1101-1102.
   PubMedGoogle Scholar
• NOGARD NB, STARK JE: Olanzapine-associated neuroleptic malignant syndrome. Pharmacotherapy (2006) 26(8):1180-1182.
   PubMed Web of Science ®Google Scholar
• RACHID F, BERTSCHY G, BONDOLFI G, AUBRY JM: Possible induction of mania or hypomania by atypical antipsychotics: an updated review or reported cases. J. Clin. Psychiatry (2004) 65(11):1537-1545.
   PubMed Web of Science ®Google Scholar
• PATEL NC, DELBELLO MP, KECK PE Jr, STRAKOWSKI SM: Ethnic differences in maintenance antipsychotic prescription among adolescents with bipolar disorder. J. Child Adolesc. Psychopharmacol. (2005) 15(6):938-946.
   PubMed Web of Science ®Google Scholar
• DELBELLO MP, LOPEZ-LARSON MP, SOUTULLO CA: Effects of race on psychiatric diagnosis of hospitalized adolescents: a retrospective chart review. J. Child Adolesc. Psychopharmacol. (2001) 11(1):95-103.
   PubMed Web of Science ®Google Scholar
• KILGUS MD, PUMARIEGA AJ, CUFFE SP: Influence of race on diagnosis in adolescent psychiatric inpatients. J. Am. Acad. Child Adolesc. Psychiatry (1995) 34(1):67-72.
   PubMed Web of Science ®Google Scholar
• STRAKOWSKI SM, KECK PE Jr, ARNOLD LM et al.: Ethnicity and diagnosis in patients with affective disorders. J. Clin. Psychiatry (2003) 64(7): 747-754.
   PubMed Web of Science ®Google Scholar
• COOPER WO, HICKSON GB, FUCHS C, ARBOGAST PG, RAY WA: New users of antipsychotic medications among children enrolled in tenn care. Arch. Pediatr. Adolesc. Med. (2004) 158(8):753-759.
   PubMed Web of Science ®Google Scholar
• GELLER B, COOK EH Jr: Serotonin transporter gene (HTTLPR) is not in linkage disequilibrium with prepubertal and early adolescent bipolarity. Biol. Psychiatry (1999) 45(9):1230-1233.
   PubMed Web of Science ®Google Scholar
• SERRETTI A, SMERALDI E: Dopamine D2 receptor gene not associated with symptomology of mood disorders. Am. J. Med. Genet. (1999) 88(4):294-297.
   PubMed Web of Science ®Google Scholar
• GELLER B, COOK EH Jr: Ultradian rapid cycling in prepubertal and early adolescent bipolarity is not in transmission disequilibrium with val/met COMT alleles. Biol. Psychiatry (2000) 47(7):605-609.
   PubMed Web of Science ®Google Scholar
• DELBELLO MP, ADLER CM, STRAKOWSKI SM: The neurophysiology of childhood and adolescent disorder. CNS Spectr. (2006) 11(4):298-311.
   PubMed Web of Science ®Google Scholar
• SCHERK H, FALKAI P: Effects of antipsychotics on brain structure. Curr. Opin. Psychiatry (2006) 19:145-150.
   PubMed Web of Science ®Google Scholar
• DELBELLO MP, CECIL KM, ADLER CM, DANIELS JP, STRAKOWSKI SM: Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study. Neuropsychopharmacology (2006) 31(6):1264-1273.
   PubMed Web of Science ®Google Scholar
• KRAMER S, MCCALL WV: Off-label prescribing: 7 steps for safer, more effective treatment. Curr. Psychiatry (2006) 5(4):14-28.
   Google Scholar

Websites

• http://www.clozapineregistry.com/pdf/insert.pdf Clozapine prescribing information/ electronical format of insert. Accessed 13 January 2007.
   Google Scholar
• http://www.risperdal.com/active/janus/en_US/assets/common/company/pi/risperdal.pdf Risperdal prescribing information/ Electronical format of insert. Accessed 13 January 2007.
   Google Scholar
• http://pi.lilly.com/us/zyprexa-pi.pdf Zyprexa prescribing information/ electronical format of insert. Accessed 13 January 2007.
   Google Scholar
• http://www.seroquel.com/cons_sch/care/index.asp Seroquel prescribing information/ electronical format of insert. Accessed 13 January 2007.
   Google Scholar
• http://www.pfizer.com/pfizer/download/uspi_geodon.pdf Geodon prescribing information/ electronical format of insert. Accessed 13 January 2007
   Google Scholar
• http://www.bms.com/cgibin/anybin.pl?sql=select%20PPI%20from%20TB_PRODUCT_PPI%20where%20PPI_SEQ=101&key=PPI Abilify prescribing information/ electronical format of insert. Accessed 13 January 2007.
   Google Scholar